`
`R Touhey Myer
`KRATZ & BARRY LLP
`800 N. West Street
`Wilmington, DE 19801
`Telephone: (302) 527-9378
`E-mail: tmyer@kratzandbarry.com
`
`Attorneys for Defendants,
`Aurobindo Pharma Ltd. and
`Aurobindo Pharma USA, Inc.
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`
`
`
`
`
`C.A. No. 3:21-cv-13247-FLW-DEA
`
`
`
`
`
`
`
`
`
`
`C.A. No. 3:21-cv-13240-FLW-DEA
`
`
`
`NOTICE OF SUBSTITUTION OF
`COUNSEL FOR DEFENDANTS,
`AUROBINDO PHARMA LTD. AND
`AUROBINDO PHARMA USA, INC.
`
`
`:
`:
`
`::
`
`
`:
`
`::
`
`
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`
`1
`
`
`TEVA BRANDED PHARMACEUTICAL
`PRODUCTS R&D, INC., and
`AUSPECT PHARMACEUTICALS, INC.,
`
`
`Plaintiffs,
`
`
`v.
`
`LUPIN LTD., and
`LUPIN PHARMACEUTICALS, INC.,
`
`
`Defendants.
`
`
`
`TEVA BRANDED PHARMACEUTICAL
`PRODUCTS R&D, INC., and
`AUSPEX PHARMACEUTICALS, INC.,
`
`
`Plaintiffs,
`
`
`v.
`
`
`AUROBINDO PHARMA LTD., and
`AUROBINDO PHARMA USA, INC.,
`
`
`
`
`Defendants.
`
`
`
`
`
`
`Case 3:21-cv-13247-FLW-DEA Document 35 Filed 12/10/21 Page 2 of 4 PageID: 418
`
`Defendants, Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc., by and through
`
`their attorneys, hereby notify the Court of their desire to substitute Karen A. Confoy, Esquire and
`
`Paul W. Kalish, Esquire of Fox Rothschild LLP for R Touhey Myer, Esquire of Kratz & Barry
`
`LLP, as counsel of record and to permit Ms. Confoy and Mr. Kalish to withdraw as counsel.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: December 10, 2021
`
`
`
`CONSENTED TO:
`
`FOX ROTHSCHILD LLP
`
`/s/ Karen A. Confoy
`Karen A. Confoy
`Paul W. Kalish
`997 Lenox Drive, Building 3
`Lawrenceville, NJ 08648
`Telephone: (609) 844-3033
`E-mail: kconfoy@foxrothschild.com
` pkalish@foxrothschild.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`KRATZ & BARRY LLP
`
`
`
`
`
`
`
` By: /s/ R Touhey Myer
`
`R Touhey Myer
`
`800 N. West Street
`
`Wilmington, DE 19801
`
`Telephone: (302) 527-9378
`
`E-mail: tmyer@kratzandbarry.com
`
`
`
`Attorneys for Defendants,
`Aurobindo Pharma Ltd. and
`Aurobindo Pharma USA, Inc.
`
`
`2
`
`
`
`Case 3:21-cv-13247-FLW-DEA Document 35 Filed 12/10/21 Page 3 of 4 PageID: 419
`
`R Touhey Myer
`KRATZ & BARRY LLP
`800 N. West Street
`Wilmington, DE 19801
`Telephone: (302) 527-9378
`E-mail: tmyer@kratzandbarry.com
`
`Attorneys for Defendants,
`Aurobindo Pharma Ltd. and
`Aurobindo Pharma USA, Inc.
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`
`
`
`
`
`C.A. No. 3:21-cv-13247-FLW-DEA
`
`
`
`
`
`
`
`
`
`
`C.A. No. 3:21-cv-13240-FLW-DEA
`
`
`
`CERTIFICATE OF SERVICE FOR
`NOTICE OF SUBSTITUTION OF
`COUNSEL FOR DEFENDANTS,
`AUROBINDO PHARMA LTD. AND
`AUROBINDO PHARMA USA, INC.
`
`
`:
`:
`
`::
`
`
`:
`
`::
`
`
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`:
`
`3
`
`
`TEVA BRANDED PHARMACEUTICAL
`PRODUCTS R&D, INC., and
`AUSPECT PHARMACEUTICALS, INC.,
`
`
`Plaintiffs,
`
`
`v.
`
`LUPIN LTD., and
`LUPIN PHARMACEUTICALS, INC.,
`
`
`Defendants.
`
`
`
`TEVA BRANDED PHARMACEUTICAL
`PRODUCTS R&D, INC., and
`AUSPEX PHARMACEUTICALS, INC.,
`
`
`Plaintiffs,
`
`
`v.
`
`
`AUROBINDO PHARMA LTD., and
`AUROBINDO PHARMA USA, INC.,
`
`
`
`
`Defendants.
`
`
`
`
`
`
`Case 3:21-cv-13247-FLW-DEA Document 35 Filed 12/10/21 Page 4 of 4 PageID: 420
`
`
`
`I hereby certify that on December 9, 2021, I presented the foregoing NOTICE OF
`
`SUBSTITUTION OF COUNSEL FOR DEFENDANTS, AUROBINDO PHARMA LTD., AND
`
`AUROBINDO PHARMA USA, INC., to the Clerk of Court using the CM/ECF system, which
`
`will send notification of such filing to all counsel of record.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: December10, 2021
`
`KRATZ & BARRY LLP
`
` By: /s/ R Touhey Myer
`
`R Touhey Myer
`
`
`
`
`
`
`
`
`
`Attorneys for Defendants,
`Aurobindo Pharma Ltd. and
`Aurobindo Pharma USA, Inc.
`
`4
`
`



